Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-02-17 to 2023-02-21
Current total value of award: $7335.86
Description: 4559985220!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML